CANDEL THERAPEUTICS, INC. - Common Stock, $0.01 par value per share (CADL)

CUSIP: 137404109

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, $0.01 par value per share
Shares outstanding
73,303,785
Total 13F shares
21,190,126
Share change
+3,231,291
Total reported value
$119,726,836
Put/Call ratio
62%
Price per share
$5.65
Number of holders
82
Value change
+$12,537,033
Number of buys
62
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 137404109?
CUSIP 137404109 identifies CADL - CANDEL THERAPEUTICS, INC. - Common Stock, $0.01 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CANDEL THERAPEUTICS, INC. - Common Stock, $0.01 par value per share (CADL) as of Q1 2025

As of 31 Mar 2025, CANDEL THERAPEUTICS, INC. - Common Stock, $0.01 par value per share (CADL) was held by 82 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,190,126 shares. The largest 10 holders included FMR LLC, BAKER BROS. ADVISORS LP, ACORN CAPITAL ADVISORS, LLC, BlackRock, Inc., VANGUARD GROUP INC, Portolan Capital Management, LLC, Halter Ferguson Financial Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and Sands Capital Ventures, LLC. This page lists 82 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.